These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31123156)

  • 41. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.
    Kelly PJ; Clarke PM; Hayes AJ; Gerdtham UG; Cederholm J; Nilsson P; Eliasson B; Gudbjornsdottir S
    Diabet Med; 2014 Aug; 31(8):954-62. PubMed ID: 24750341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trimethylamine-
    Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
    Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
    [No Abstract]   [Full Text] [Related]  

  • 44. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
    Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
    Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
    Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
    Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
    Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
    Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trimethylamine N-oxide and prognosis in acute heart failure.
    Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
    Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.
    Huang Y; Wu Y; Zhang Y; Bai H; Peng R; Ruan W; Zhang Q; Cai E; Ma M; Zhao Y; Lu Y; Zheng L
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.
    Sanchez-Gimenez R; Peiró ÓM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Papandreou C; Bardaji A
    Front Cardiovasc Med; 2022; 9():1000815. PubMed ID: 36211587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
    Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
    Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowiński A; Ufnal M
    Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
    Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
    J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.